"Spain Pharmaceuticals & Healthcare Report Q2 2014" Is Now Available at Fast Market Research
Despite the Spanish economy returning to growth in 2014, the country's pharmaceuticals and healthcare sectors show no sign of following suit. The Spanish government's ongoing cash flow troubles and aggressive fiscal austerity measures, which focus heavily on cost containment in the healthcare sector, will continue to negatively impact pharmaceutical companies operating in Spain.
View full press release